NFKB1 and Alzheimer disease: Finally, from the field of phytotherapy, an in vitro study showed that Ginsenoside F1 suppresses the SASP in astrocytes by downregulating the p38MAPK-dependent NF-κB activity [184], a pathway upregulated in AD.